Trastuzumab Emtansine plus Pertuzumab Versus Taxane plus Trastuzumab plus Pertuzumab after Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breas...

by Barrios, C., Bonnefoi, H., Boulet, T., De Laurentiis, M., Ellis, P.A, Fehrenbacher, L., Gianni, L., Gralow, J., Harbeck, N., Huang, C.-S, Im, S.-A, Im, Y.-H, Ito, Y., Krop, I.E, Liu, H., Macharia, H., Nowecki, Z., Shah, J., Song, C., Swain, S.M, Toi, M., Trask, P., Winer, E.P
Published 2022

Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a ra...

by Abramson, V., Albain, K., Ardman, B., Barroso-Sousa, R., Barry, W., Bose, R., Briccetti, F., Burstein, H., Cheng, K., Constantine, M., Dang, C., DeFusco, P., DeMeo, M., Faggen, M., Forero-Torres, A., Gadi, V.K, Garrett, A.M, Gelber, R.D, Hart, L., Hu, J., Isakoff, S.J, Jankowitz, R.C, Krop, I., Liu, M., Marcom, K., Mulvey, T., Nanda, R., Partridge, A., Pohlmann, P.R, Ramaswamy, B., Reeder-Hayes, K., Rimawi, M., Rosenberg, S.M, Ruddy, K.J, Rugo, H.S, Schneider, B., Tarantino, P., Tayob, N., Tolaney, S.M, Trippa, L., Tung, N., Valero, V., Van Poznak, C., Weckstein, D., Winer, E.P, Wolff, A.C, Yardley, D.A, Zheng, Y., Zuckerman, D.
Published 2022